Copy For Citation
Ozdemir Z. N., Kircali E., Şahin U., Seval G., Bozdağ S. C., Toprak S. K., ...More
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol.22, no.8, pp.596-600, 2022 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
22
Issue:
8
-
Publication Date:
2022
-
Doi Number:
10.1016/j.clml.2022.02.007
-
Journal Name:
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
-
Page Numbers:
pp.596-600
-
Keywords:
Ph-acute lymphoblastic leukemia, Pre-transplant consolidation therapy, Allogeneic hematopoietic stem cell transplantation, First complete remission, Myeloablative conditioning, STEM-CELL TRANSPLANTATION, IMPROVED SURVIVAL
-
Ankara University Affiliated:
Yes
Abstract
The benefit of pre-transplant consolidation treatments remains unclear in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Here, 57 patients with ALL who underwent allo-HSCT with myeloablative conditioning in first complete remission were evalu-ated. Overall survival was significantly better in patients receiving >= 2 consolidation compared to patients who receiving < 2 consolidation (P = 0.03).